Author contributions
C.P. and M.B. collected mycological data, performed antifungal susceptibility testing and the EUCAST checkboard method and participated in the writing. C.V. participated in the therapeutic decision, collected clinical data and participated in the writing. A.L. participated in the therapeutic decision and in the writing. A.M. participated in the therapeutic decision, collected clinical data and participated in the writing. A.F. participated in the therapeutic decision, collected data and wrote the paper.